Clinical trial
Effects of Body Mass Index on the Hyperemic Response to Regadenoson
NCT00859833 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Body Mass Index on the Hyperemic Response to Regadenoson
- Lead sponsor
- University of Utah
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- July 31, 2010
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
decreased vascular flow, endothelial dysfunction, obesity